Avestar Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$768K Sell
9,002
-762
-8% -$69K 0.06% 265
2026
Q2
$895K Buy
9,764
+428
+5% +$37.4K 0.05% 266
2026
Q1
$796K Buy
9,336
+747
+9% +$66.6K 0.05% 266
2025
Q4
$679K Buy
8,589
+4,973
+138% +$390K 0.04% 279
2025
Q3
$289K Sell
3,616
-4,221
-54% -$360K 0.02% 418
2025
Q2
$712K Buy
7,837
+3,199
+69% +$292K 0.05% 271
2025
Q1
$435K Sell
4,638
-504
-10% -$45.1K 0.04% 310
2024
Q4
$467K Buy
5,142
+649
+14% +$61.9K 0.04% 302
2024
Q3
$466K Buy
4,493
+394
+10% +$40.2K 0.05% 266
2024
Q2
$398K Buy
4,099
+412
+11% +$38K 0.04% 285
2024
Q1
$332K Buy
3,687
+906
+33% +$76.8K 0.03% 321
2023
Q4
$222K Buy
+2,781
New +$209K 0.03% 343
2019
Q3
– Sell
-197
Closed -$13K – 299
2019
Q2
$13K Hold
197
– – 0.01% 456
2019
Q1
$13K Hold
197
– – 0.01% 434
2018
Q4
$10K Buy
197
+1
+0.5% +$63 0.01% 436
2018
Q3
$11K Buy
196
+8
+4% +$533 0.01% 448
2018
Q2
$10K Buy
188
+21
+13% +$1.37K 0.01% 460
2018
Q1
$11K Buy
167
+21
+14% +$1.51K 0.01% 404
2017
Q4
$10K Buy
+146
New +$10.7K 0.01% 439

Other funds holding CL

Avestar Capital's CL Position: Q3 2026 in Review

Avestar Capital reduced its Colgate-Palmolive (CL) stake by 7.8% in Q3 2026, selling an estimated $69K and leaving 9,002 shares worth $768K. The position accounts for 0.06% of the portfolio, ranked #265.

Avestar Capital first reported a position in CL in Q4 2017 and has held it in 19 quarters since. The position peaked at $895K in Q2 2026. 1,131 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Avestar Capital held 9,002 shares of Colgate-Palmolive worth $768K as of Q3 2026.
  • Avestar Capital sold 762 Colgate-Palmolive shares in Q3 2026, an estimated $69K.
  • Colgate-Palmolive made up 0.06% of Avestar Capital's portfolio in Q3 2026, its #265 holding.
  • Avestar Capital first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 19 quarters since.
  • Avestar Capital's Colgate-Palmolive position peaked at $895K in Q2 2026.
  • 1,131 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Avestar Capital's 13F filing for Q3 2026, filed 28 Oct 2026.